Cyfuse Biomedical KK: Notice regarding the award for our product “Human 3D Mini Liver”
Cyfuse Biomedical KK: Notice regarding revisions to earnings forecasts for the fiscal year ending 2024/12
Cyfuse Biomedical KK: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: NSK Co., Ltd. and Cyfuse Co., Ltd. succeeded in developing new technology for automating product manufacturing processes in the field of regenerative and cell medicine
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: Change Report
Cyfuse Biomedical KK: Notice regarding business adoption for the Reiwa 6 New Product/New Technology Development Grant Project
Cyfuse Biomedical KK: Collection of questions and answers on financial results for the 2nd quarter of the fiscal year ending 2024/12
Cyfuse Biomedical KK: Earnings conference materials for the second quarter of the fiscal year ending December 2024.
Cyfuse Biomedical KK: Confirmation letter
Cyfuse Biomedical KK: Interim Report - 15th period (January 1, 2024 - December 31, 2024)
Cyfuse Biomedical KK: Supplementary explanation materials for the 2nd quarter of the fiscal year ending December 2024.
Cyfuse Biomedical KK: Financial results announcement for the second quarter (interim period) of December 2024, based on Japanese accounting standards (non-consolidated).
Cyfuse Biomedical KK: Change report.
Cyfuse Biomedical KK: Change Report
Cyfuse Biomedical KK: New technology development through collaboration in the field of regeneration and cell therapy by Iwaya Sangyo Co., Ltd. and Saifuse Co., Ltd.
Cyfuse Biomedical KK: Change report.
Cyfuse Biomedical KK: Announcements of individual stocks related to the adoption of the grant for improving productivity in manufacturing, commerce, and service.
Cyfuse Biomedical KK: Change Report
No Data
No Data